Hepatitis
Hepatitis
Hepatitis means inflammation of the liver. This can be caused by a variety of factors, including heavy alcohol or drug use, drug toxicities and viral infections. Shared transmission routes mean that many people infected by HIV are also at risk of viral hepatitis. This chapter looks at a number of hepatitis viruses alongside key features relevant to co-infection with HIV.
NAM's Patient information
Booklets:
- HIV & hepatitis
We have recently re-launched the booklet to coincide with the World Hepatitis Awareness Day.
To view all booklets, click here
Factsheets
To view all factsheets, click here
Hepatitis articles from NAM's newsletters
AIDS Treatment Update
- ATU 164, March 2007
HIV and hepatitis C coinfection update - ATU154,March 2006
The ABCs of liver disease
HIV & AIDS Treatment in Practice
- HATIP #61, 19th January 2006
Hepatitis special - HATIP #65, 16th March 2006
Management of HIV and hepatitis B or C coinfection in resource-limited settings
HIV Weekly
- HIV Weekly August 29th 2007
HIV & hepatitis C - HIV Weekly August 15th 2007
HIV & hepatitis B - HIV Weekly June 19th 2007
HIV & hepatitis - HIV Weekly June 12th 2007
HIV & hepatitis - HIV Weekly May 29th 2007
Hepatitis C - HIV Weekly May 22nd 2007
Hepatitis C - HIV Weekly May 15th 2007
Hepatitis C
Hepatitis news
- Does tenofovir increase the risk of efavirenz-associated liver side-effects?
- HIV reduces body's ability to control hepatitis C replication
- BHIVA: No evidence of a hepatitis C epidemic in HIV negative gay men
- Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals
- Tenofovir shows excellent promise as a treatment for hepatitis B monoinfection
- Patient groups campaign for better HIV/HCV treatment and care in southern Europe
- Revised US labelling for darunavir/ritonavir recommends caution for patients with liver problems
- HIV-positive gay men being infected with HCV soon after HIV; cases of HCV superinfection reported
- CROI: Choice of nucleoside analogue in co-infection: tenofovir associated with better response to HCV therapy
- CROI: Pegylated interferon maintenance therapy demonstrates no benefit in HIV/hepatitis C coinfected individuals